Dr. Reddy’s Q2 and H1 FY17 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/20/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- ICC sets July 24 vote on whether to remove chief prosecutor Karim Khan, WSJ reports
Dr. Reddys Labs (RDY) Reports Q2 EPS of $0.27
October 25, 2016 7:24 AM EDTDr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $0.27, versus $0.63 reported last year. Revenue for the quarter came in at $539 billion, versus $599 billion reported last year.
Commenting on the results, Co-chairman and CEO, G V Prasad said, All our major businesses have shown... More
